Form D · Biotechnology

Cue Biopharma, Inc.

Boston, MA · CIK 0001645460

Offering snapshot reported Jul 22, 2026 · SEC filing

Reported sold
$50M
Offering amount: $50M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 13, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 22, 2026Initial$49,999,927No comparison4SEC filing
May 14, 2026Initial$29,999,992No comparison118SEC filing
Nov 21, 2022Initial$29,999,993No comparison64SEC filing
Dec 30, 2016Amendment$16,414,900-$3,585,100vs Dec 22, 2016133SEC filing
Dec 22, 2016Initial$20,000,000No comparison133SEC filing
Jun 19, 2015Initial$0No comparison1SEC filing
Jun 19, 2015Initial$10,000,000No comparison121SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-591745

Source: Form D, filed Jul 22, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steven Almo Executive
Daniel Baker Executive
Dominic Borie Executive
Jill M. Broadfoot Director
Daniel Camardo Director
Rodolfo Chaparro Executive
Anthony Digiandomenico Director
Anthony Di Giandomenico Director
Frederick Driscoll Director
Aaron Fletcher Director
Pamela Garzone Director
Cameron Gray Director
Tamar Howson Director
Peter Kiener Director
Shao Lee Lin Director, Executive
Christopher Marlett Director
Steven Mcknight Director
Viola Meehan Director
Michael Meluzio Executive
Kerri Ann Millar Executive
Frank Morich Director
Patricia Nasshorn Executive
Daniel R. Passeri Director, Executive
Ken Pienta Executive
Sumita Ray Executive
Colin Sandercock Executive
Pasha Sarraf Director
Gary Schuman Executive
Ronald Seidel Iii Executive
Barry Simon Director
Anish Suri Executive
Patrick Verheyen Director
Amy Wang Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
40 Guest Street
Boston, MA, 02135
Phone: 617-949-2680